Jinxin Fertility Group IPO: Valuation Reasonable for the Trade-Offs
Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. It announced its IPO price...
975 Views
Jinxin Fertility Group IPO: 4Q Update Is Good but Is It Sustainable?
Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...
858 Views
Jinxin Fertility (锦欣生殖) IPO - Worth a Look Given the Sector, Existing Shareholders and Cornerstone
Jinxin Fertility Co Ltd (1659778D CH) plans to raise up to US$390m in its Hong Kong IPO. Ke Yan, CFA, FRM has covered most details of the company...
847 Views
Jinxin Fertility Group IPO Preview: Baby Boom or Bust?
Jinxin Fertility Co Ltd (1659778D CH) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...
923 Views
ECM Weekly (8 Jun 2019) -ESR Cayman, Shanghai Henlius, Edvantage, JH Education
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
678 Views